A. Laihinen

1.8k total citations
38 papers, 1.3k citations indexed

About

A. Laihinen is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, A. Laihinen has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 15 papers in Cellular and Molecular Neuroscience and 9 papers in Cognitive Neuroscience. Recurrent topics in A. Laihinen's work include Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological disorders and treatments (20 papers) and Neuroscience and Neuropharmacology Research (7 papers). A. Laihinen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological disorders and treatments (20 papers) and Neuroscience and Neuropharmacology Research (7 papers). A. Laihinen collaborates with scholars based in Finland, Germany and Italy. A. Laihinen's co-authors include Juha O. Rinne, U. K. Rinne, Ulla Ruotsalainen, Kjell Någren, Jörgen Bergman, Pertti Lehikoinen, Vesa Oikonen, Hanna Ruottinen, Olof Solin and Merja Haaparanta‐Solin and has published in prestigious journals such as NeuroImage, Neurology and Brain Research.

In The Last Decade

A. Laihinen

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Laihinen Finland 21 806 611 308 148 145 38 1.3k
David J. Wyper United Kingdom 19 620 0.8× 378 0.6× 250 0.8× 183 1.2× 235 1.6× 36 1.2k
R. Hilker Germany 16 701 0.9× 346 0.6× 204 0.7× 187 1.3× 137 0.9× 25 1.1k
Heidi Cartwright Australia 15 976 1.2× 659 1.1× 264 0.9× 141 1.0× 207 1.4× 17 1.5k
E.M.J. Foncke Netherlands 26 1.3k 1.7× 568 0.9× 327 1.1× 137 0.9× 120 0.8× 45 1.7k
Praveen Dayalu United States 17 568 0.7× 342 0.6× 328 1.1× 120 0.8× 192 1.3× 29 1.1k
J. O. Rinne Finland 14 642 0.8× 338 0.6× 268 0.9× 95 0.6× 92 0.6× 28 1.1k
Sid Gilman United States 13 329 0.4× 293 0.5× 213 0.7× 74 0.5× 78 0.5× 36 848
Cliff Shults United States 11 996 1.2× 410 0.7× 210 0.7× 78 0.5× 180 1.2× 12 1.4k
Franck Durif France 22 1.2k 1.5× 524 0.9× 208 0.7× 126 0.9× 63 0.4× 69 1.5k
Lorenzo Kiferle Italy 20 871 1.1× 551 0.9× 184 0.6× 74 0.5× 196 1.4× 30 1.3k

Countries citing papers authored by A. Laihinen

Since Specialization
Citations

This map shows the geographic impact of A. Laihinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Laihinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Laihinen more than expected).

Fields of papers citing papers by A. Laihinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Laihinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Laihinen. The network helps show where A. Laihinen may publish in the future.

Co-authorship network of co-authors of A. Laihinen

This figure shows the co-authorship network connecting the top 25 collaborators of A. Laihinen. A scholar is included among the top collaborators of A. Laihinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Laihinen. A. Laihinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tedroff, Joakim, Sten‐Magnus Aquilonius, A. Laihinen, et al.. (2009). Striatal kinetics of [11C]-(+)-nomifensine and 6-[18F]fluoro-L-dopa in Parkinson's disease measured with positron emission tomography. Acta Neurologica Scandinavica. 81(1). 24–30. 5 indexed citations
2.
Alihanka, J., et al.. (2009). Sleep movements and associated autonomic nervous activities in patients with Parkinson's disease. Acta Neurologica Scandinavica. 69(S98). 63–64.
3.
Laihinen, A. & Ulrike Halsband. (2006). PET imaging of the basal ganglia. Journal of Physiology-Paris. 99(4-6). 406–413. 8 indexed citations
4.
Halsband, Ulrike, Bernd J. Krause, Hannu Sipilä, Mika Teräs, & A. Laihinen. (2002). PET studies on the memory processing of word pairs in bilingual Finnish–English subjects. Behavioural Brain Research. 132(1). 47–57. 26 indexed citations
5.
Brück, Anna, Raija Portin, A. Laihinen, et al.. (2001). Positron emission tomography shows that impaired frontal lobe functioning in Parkinson’s disease is related to dopaminergic hypofunction in the caudate nucleus. Neuroscience Letters. 311(2). 81–84. 148 indexed citations
6.
Pantano, Patrizià, François Chollet, Olaf B. Paulson, et al.. (2001). EFNS Task Force on Teaching of Neuroimaging in Neurology Curricula in Europe: present status and recommendations for the future. European Journal of Neurology. 8(6). 541–548. 3 indexed citations
7.
Laihinen, A., Hanna Ruottinen, Juha O. Rinne, et al.. (2000). Risk for Parkinson’s disease: twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PET. Journal of Neurology. 247(S2). 110–113. 29 indexed citations
8.
Rinne, Juha O., Christer Hublin, Markku Partinen, et al.. (1996). Striatal Dopamine D1 receptors in narcolepsy: A PET study with [11C]NNC 756. Journal of Sleep Research. 5(4). 262–264. 8 indexed citations
9.
Ruottinen, Hanna, Juha O. Rinne, Ulla Ruotsalainen, et al.. (1995). Striatal [18F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson's disease. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 10(2-3). 91–106. 32 indexed citations
10.
Rinne, Juha O., A. Laihinen, Hanna Ruottinen, et al.. (1995). Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride. Journal of the Neurological Sciences. 132(2). 156–161. 90 indexed citations
11.
Rinne, Juha O., Christer Hublin, Markku Partinen, et al.. (1995). Positron emission tomography study of human narcolepsy. Neurology. 45(9). 1735–1738. 23 indexed citations
12.
Laihinen, A., et al.. (1995). PET examination of the monoamine transporter with [11c]β‐CIT and [11c]β‐CFT in early parkinson's disease. Synapse. 21(2). 97–103. 58 indexed citations
13.
Laihinen, A., J. O. Rinne, Hanna Ruottinen, et al.. (1994). PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756.. PubMed. 35(12). 1916–20. 23 indexed citations
14.
Laihinen, A., et al.. (1992). Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease. Acta Neurologica Scandinavica. 86(6). 593–595. 24 indexed citations
15.
Rinne, Juha O., A. Laihinen, Kjell Någren, et al.. (1990). PET demonstrates different behaviour of striatal dopamine D‐1 and D‐2 receptors in early Parkinson's disease. Journal of Neuroscience Research. 27(4). 494–499. 56 indexed citations
16.
Tenovuo, Olli, et al.. (1990). Brain substance P receptors in Parkinson's disease.. PubMed. 53. 145–8. 12 indexed citations
17.
Laihinen, A., et al.. (1987). Dopamine receptor function in Parkinson's disease--in vivo studies with prolactin responses.. PubMed. 45. 249–52. 1 indexed citations
18.
Martin, W. R. Wayne, A. Jon Stoessl, M. Adam, et al.. (1987). Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.. PubMed. 45. 95–8. 67 indexed citations
19.
Laihinen, A., et al.. (1979). Pontine gigantocellular field neuron activity time-locked with the PGO waves in the transitional phase of sleep in the cat.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 57(5). 357–61. 1 indexed citations
20.
Pekkarinen, A., et al.. (1960). The adrenosympathetic and adrenocortical function in cardiac insufficiency∗. The American Journal of Cardiology. 5(5). 604–612. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David J. Wyper Breakdown of academic impact, for papers by R. Hilker Breakdown of academic impact, for papers by Heidi Cartwright Breakdown of academic impact, for papers by E.M.J. Foncke Breakdown of academic impact, for papers by Praveen Dayalu Breakdown of academic impact, for papers by J. O. Rinne Breakdown of academic impact, for papers by Sid Gilman Breakdown of academic impact, for papers by Cliff Shults Breakdown of academic impact, for papers by Franck Durif Breakdown of academic impact, for papers by Lorenzo Kiferle
Rankless by CCL
2026